HCW Biologics Inc.
HCWB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $692,067 | $1,767,729 | $2,743,626 | $3,319,295 |
| - Cash | $4,675 | $3,595 | $22,326 | $11,731 |
| + Debt | $13,693 | $6,304 | $6,410 | $0 |
| Enterprise Value | $701,085 | $1,770,438 | $2,727,710 | $3,307,564 |
| Revenue | $2,567 | $2,842 | $6,722 | $0 |
| % Growth | -9.7% | -57.7% | – | – |
| Gross Profit | $959 | $560 | $2,586 | -$544 |
| % Margin | 37.4% | 19.7% | 38.5% | – |
| EBITDA | -$27,681 | -$23,576 | -$14,056 | -$12,319 |
| % Margin | -1,078.4% | -829.6% | -209.1% | – |
| Net Income | -$30,024 | -$24,994 | -$14,901 | -$12,862 |
| % Margin | -1,169.7% | -879.5% | -221.7% | – |
| EPS Diluted | -0.77 | -0.7 | -0.41 | -0.35 |
| % Growth | -10% | -70.7% | -17.1% | – |
| Operating Cash Flow | -$14,227 | -$22,514 | -$10,386 | -$10,976 |
| Capital Expenditures | -$262 | -$6,203 | -$10,275 | -$47 |
| Free Cash Flow | -$14,489 | -$28,717 | -$20,661 | -$11,023 |